Navigation Links
Interleukin Genetics Announces Conference Call To Discuss Second Quarter 2009 Results
Date:8/6/2009

WALTHAM, Mass., Aug. 6 /PRNewswire-FirstCall/ -- Interleukin Genetics, Inc. (NYSE Amex: ILI) announced today that it will host a conference call and webcast on Thursday, August 13, 2009, at 4:30 p.m. EDT to review the Company's business developments and second quarter financial results.

To access the live call, dial 877-440-5796 (domestic) or 719-325-4847 (international). The live webcast and replay access of the teleconference will be available on the Investors section of the Company's website at http://www.ilgenetics.com.

About Interleukin Genetics

Interleukin Genetics, Inc. develops and markets genetic tests, including its new brand of Inherent Health(TM) genetic test products that empower consumers to maintain health and wellness, and assists pharmaceutical companies in the development and marketing of targeted therapeutics. The Company leverages its research, intellectual property, and biomarker development experience to facilitate the emerging personalized health market. Interleukin Genetics is headquartered in Waltham, MA. For more information please visit www.ilgenetics.com.


'/>"/>
SOURCE Interleukin Genetics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Interleukin Genetics Announces Management and Board Appointments
2. Interleukin Genetics President and Chief Scientific Officer to Present at Immunotoxicology V Conference
3. Interleukin Genetics, Inc. Reports Third Quarter 2007 Financial Results
4. Interleukin Genetics Announces Conversion of $2.04 Million of Debt Into Common Stock
5. Interleukin Genetics Enters into New Clinical Research Collaboration with Alticor
6. Interleukin Genetics Retains Top Life Science Communications Firms
7. Interleukin Genetics Announces Conference Call and Webcast to Discuss Fourth Quarter and Year End 2007 Business Results
8. Interleukin Genetics Appoints Eliot M. Lurier Chief Financial Officer
9. Interleukin Genetics Announces Conference Call and Webcast to Discuss First Quarter 2008 Business Results
10. Interleukin Genetics to Present at Rodman & Renshaw 5th Annual Global Healthcare Conference
11. Interleukin Genetics Welcomes the Signing of the Genetic Information Nondiscrimination Act (GINA)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... ... March 21, 2017 , ... Functional near-infrared spectroscopy (fNIRS), an ... explored as a way to track the brain’s response to acute pain in adults ... cold pressor test ,” published today in the journal Neurophotonics , by ...
(Date:3/22/2017)... -- Personal Genome Diagnostics Inc. (PGDx) today announced an ... U.S. Department of Veterans Affairs (VA) that replaces ... new CancerSELECT ™ 125 test. CancerSELECT 125 ... that includes microsatellite instability status (MSI), a biomarker ... inhibitor immunotherapies. CancerSELECT 125 will be available to ...
(Date:3/20/2017)... ... March 20, 2017 , ... ... endogenous hormones to regulate homeostasis via their cognate nuclear receptors. By either ... reproductive, neurological, proliferative, and immunological disorders. EDC exposure can occur directly, through ...
(Date:3/20/2017)... ... 2017 , ... Charm Sciences, Inc. is pleased to introduce ... Peel Plate microbial test colonies, stores plate images, exports and archives data from ... computer, and is accurate within 10% of an experienced microbiologist’s visual count. For ...
Breaking Biology Technology:
(Date:2/28/2017)... --  Acuant , a leading provider of data capture ... new and core technologies building upon the acquisition of ... desktop Acuant FRM TM facial recognition and match ... manual review of identity documents by accredited professionals. ... most accurate capture software to streamline workflows by securely ...
(Date:2/26/2017)... -- Securus Technologies, a leading provider of civil and ... corrections and monitoring, announces the appointment of a ... often, too many offenders return to jail or ... to tackle this ongoing problem and improve the ... significant steps are underway, Securus continues to invest ...
(Date:2/21/2017)... LONDON , February 21, 2017 ... um 70 Millionen US-Dollar wachsen. Nach einem Gespräch mit mehr ... es einige Hindernisse zu überwinden gilt, um diese Prognose ... ... unter anderem die Mobilisierung der finanziellen Mittel für die ...
Breaking Biology News(10 mins):